Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 85118-33-8 | Product Number: G0405
Gaboxadol Hydrochloride
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- 4,5,6,7-Tetrahydroisoxazolo[5,4-c]pyridin-3-ol Hydrochloride
Product Documents:
| Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
|---|---|---|---|---|---|
| 25MG |
$159.00
|
3 | 2 | ≥40 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | G0405 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__6H__8N__2O__2·HCl = 176.60 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 85118-33-8 |
| Related CAS RN | 64603-91-4 |
| Reaxys Registry Number | 6534899 |
| PubChem Substance ID | 253659629 |
| Merck Index (14) | 4321 |
| MDL Number | MFCD00055180 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Elemental analysis(Nitrogen) | 15.40 to 16.30 % |
Properties (reference)
| Melting Point | 236 °C |
GHS
Related Laws:
| RTECS# | NY3398000 |
Transport Information:
| HS Number | 2934.99.9001 |
Application
Gaboxadol Hydrochloride: A γ-Aminobutyric Acid Subtype A (GABAA) Receptor Agonist
Gaboxadol hydrochloride, also known as THIP, is a direct-acting γ-aminobutyric acid subtype A (GABAA) receptor agonist. GABAA receptor is widely considered to be an important target for most clinically effective sedative-hypnotic compounds. However, the clinical development program for gaboxadol was discontinued in 2007. (The product is for research purpose only.)
References
- Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptors
- GABAA receptor α4 subunits mediate extrasynaptic inhibition in thalamus and dentate gyrus and the action of gaboxadol
- An extrasynaptic GABAA receptor mediates tonic inhibition in thalamic VB neurons
- Gaboxadol - a new awakening in sleep(a review)
- GABAA agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic(a review)
- Development and validation of a selective and sensitive bioanalytical procedure for the quantitative determination of gaboxadol in human plasma employing mixed mode solid phase extraction and hydrophilic interaction liquid chromatography with tandem mass spectroscopic detection
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.